-

Electromed, Inc. to Participate in the Inaugural EF Hutton Global Conference

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the Inaugural EF Hutton Global Conference on May 10-11, 2023 at the Plaza Hotel in New York, New York. Management will be available for one-on-one meetings on Thursday, May 11, 2023.

About Electromed, Inc.

Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. It is headquartered in New Prague, Minnesota, and was founded in 1992. Further information about Electromed can be found at www.smartvest.com.

Contacts

Brad Nagel, Chief Financial Officer
(952) 758-9299
investorrelations@electromed.com

Mike Cavanaugh, Investor Relations
ICR Westwicke
(617) 877-9641
mike.cavanaugh@westwicke.com

Electromed, Inc.

NYSEAM:ELMD

Release Summary
Electromed, Inc. to Participate in the Inaugural EF Hutton Global Conference
Release Versions

Contacts

Brad Nagel, Chief Financial Officer
(952) 758-9299
investorrelations@electromed.com

Mike Cavanaugh, Investor Relations
ICR Westwicke
(617) 877-9641
mike.cavanaugh@westwicke.com

More News From Electromed, Inc.

Electromed, Inc. Announces First Quarter Fiscal 2026 Results

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed Reports First Quarter Fiscal 2026 Results...

Electromed, Inc. to Report Q1 Fiscal 2026 Financial Results on November 12, 2025

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. to Report Q1 Fiscal 2026 Financial Results on November 12, 2025...

Electromed, Inc. Announces Share Repurchase Authorization

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Announces Share Repurchase Authorization...
Back to Newsroom